After hours: March 17 at 4:05:01 PM EDT Loading Chart for SLRN ...

LOS ANGELES, March 13, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative ...

Concentra Biosciences' $3/share + CVR bid for SLRN is superior to the ALMS stock-for-stock offer, presenting us with a 20% spread in favor of its bid. SLRN's remaining Phase 2 asset, Lonigutamab ...

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

In this article, we are going to take a look at where Acelyrin, Inc. (NASDAQ:SLRN) stands against the other micro cap stocks. Just as we overlook loose change, micro-cap stocks are often ignored ...

Acelyrin (NASDAQ:SLRN) announced Thursday a decision to adopt a limited-duration stockholder rights plan, also known as a poison pill, after Tang Capital Partners rapidly accumulated 8.8% of the ...

The announcement came days after Acelyrin (NASDAQ:SLRN) received an unsolicited buyout offer from Concentra Biosciences, controlled by Tang Capital Partners, to acquire it for $3.00 per share in ...

It was a special occasion for the mother-daughter duo Vanna White/Instagram Vanna White waited decades to get her first tattoo and when she finally took the plunge, she knew exactly who to call.